Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05204459 · ClinicalTrials.gov registry record

MS-ResearchBiomarkerS

A clinical trial of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT05204459 is a study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting) that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 1,000 participants, above the 582-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05204459, a study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.

Conditions Studied

Multiple Sclerosis Multiple Sclerosis (Relapsing Remitting) Neurologic Disorder Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Clinically Isolated Syndrome Radiologically Isolated Syndrome Neurologic Autoimmune Disease Neuromyelitis Optica Spectrum Disorders Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2021-11-11
Est. Completion 2041-11-11

Sponsor

Cedars-Sinai Medical Center

339 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05204459

The ClinicalTrials.gov registry entry for NCT05204459 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 582-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (72% higher). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT05204459 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05204459 about?

NCT05204459 is a clinical study titled "MS-ResearchBiomarkerS". This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain...

What is the current status of trial NCT05204459?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-11-11. Estimated completion is 2041-11-11.

What conditions does trial NCT05204459 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Multiple Sclerosis (Relapsing Remitting), Neurologic Disorder, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive.

Who is sponsoring clinical trial NCT05204459?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05204459 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Multiple Sclerosis (Relapsing Remitting)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.